Evaluating Posterior Cruciate Ligament Integrity in Inflammatory Arthritis Patients Prescribed Biologic Agents: A Radiological Case-Control Study
Open Access
- 5 February 2021
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 13 (2)
Abstract
Patients with inflammatory arthropathies present a significant challenge to the arthroplasty surgeon when they present with symptomatic degenerative changes of their knee joint. Debate is ongoing regarding the selection of implants for this cohort of patients. There is conflicting evidence for the use of posterior-stabilising (PS) over cruciate-retaining (CR) designs in this cohort. Biologics are licensed for use in moderate-to-severe disease that has not responded to conventional treatment. To our knowledge, there are no studies that have assessed the integrity of the posterior cruciate ligament (PCL) on magnetic resonance imaging (MRI) in these patients with more advanced disease prescribed biologic agents. The aim of this study is to assess the integrity of the PCL on MRI in patients with inflammatory arthritis who are prescribed biologic agents. A case-control study was performed, with cases identified through chart review to confirm prescription of biologic agents for inflammatory arthropathies, who also had contemporaneous MRI knee scans performed. Knee MRIs for age- and sex-matched controls with osteoarthritis (OA) and meniscal pathology were identified from the National Joint Registry and the Hospital In-Patient Enquiry (HIPE), respectively. The MRIs were reviewed by two musculoskeletal radiologists who were blinded to the clinical details. They were asked to assess the MRIs to determine PCL integrity, synovial Inflammation, and any associated pathology. No difference was noted in the rate of synovitis, PCL attenuation, or PCL tears between the OA and inflammatory arthropathy groups (p > 0.05). The results of this study show no difference in the integrity and continuity of the PCL in those patients for age- and sex-matched controls on MRI. This finding lends support to the use of CR total knee arthroplasty in patients with inflammatory arthropathy on biologic agents.Keywords
This publication has 15 references indexed in Scilit:
- Rationale of Cruciate Retaining Design in Rheumatoid Arthritis: A Review of Clinical Analysis and its Role in Rheumatoid ArthritisThe Open Orthopaedics Journal, 2017
- Long-term results of cruciate-retaining total knee replacement in patients with rheumatoid arthritis: a minimum 15-year reviewCanadian Journal Of Surgery, 2015
- Posterior cruciate‐retaining versus posterior stabilized total knee arthroplasty: a meta‐analysis of randomized controlled trialsKnee Surgery, Sports Traumatology, Arthroscopy, 2012
- Total Knee Arthroplasty in Rheumatoid ArthritisKnee Surgery & Related Research, 2012
- Posterior Cruciate Ligament-Retaining Total Knee Arthroplasty in Patients with Rheumatoid ArthritisJournal of Bone and Joint Surgery, 2011
- Increased Long-Term Survival of Posterior Cruciate-Retaining Versus Posterior Cruciate-Stabilizing Total Knee ReplacementsJournal of Bone and Joint Surgery, 2011
- Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of CareClinical Therapeutics, 2011
- Cruciate ligament integrity in osteoarthritis of the kneeArthritis & Rheumatism, 2005
- Rheumatoid arthritis: regulation of synovial inflammationThe International Journal of Biochemistry & Cell Biology, 2004
- The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritisArthritis & Rheumatism, 1998